Targeted management of adenomyosis: frozen embryo transfer outcomes with GnRH-agonist and letrozole therapy: a case series
Journal of Medical Case Reports · 09.03.2026 · 20 (1)
DOI: 10.1186/s13256-026-05907-1 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Medical Case Reports, online erschienen am 09.03.2026. Verfasst von Maryam Farid Mojtahedi und 4 weiteren Autor:innen. Beteiligte Einrichtung: ART Fertility Clinic, Jumeira Street 869, Umm Suqeim 3, Dubai, United Arab Emirates. maryam.mojtahedi@artfertilityclinics.com. Hauptthemen laut MEDLINE: Letrozole, Embryo Transfer, Adenomyosis, Gonadotropin-Releasing Hormone. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ART Fertility Clinic, Jumeira Street 869, Umm Suqeim 3, Dubai, United Arab Emirates. maryam.mojtahedi@artfertilityclinics.com.
- ART Fertility Clinics, Abu Dhabi, United Arab Emirates.
Zitieren
APA
Mojtahedi, M. F., Melado, L., Edades, J., Lawrenz, B., & Fatemi, H. M. (2026). Targeted management of adenomyosis: frozen embryo transfer outcomes with GnRH-agonist and letrozole therapy: a case series. Journal of Medical Case Reports, 20(1). https://doi.org/10.1186/s13256-026-05907-1
Vancouver
Mojtahedi MF, Melado L, Edades J, Lawrenz B, Fatemi HM. Targeted management of adenomyosis: frozen embryo transfer outcomes with GnRH-agonist and letrozole therapy: a case series. Journal of Medical Case Reports. 2026;20(1). doi:10.1186/s13256-026-05907-1
BibTeX
@article{Mojtahedi2026,
author = {Mojtahedi, Maryam Farid and Melado, Laura and Edades, Jonalyn and Lawrenz, Barbara and Fatemi, Human M},
title = {Targeted management of adenomyosis: frozen embryo transfer outcomes with GnRH-agonist and letrozole therapy: a case series},
journal = {Journal of Medical Case Reports},
year = {2026},
volume = {20},
number = {1},
doi = {10.1186/s13256-026-05907-1}
}
EUVIMED